Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.

Vanness DJ, Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Gareen IF, Herman BA, Kuntz KM, Zauber AG, van Ballegooijen M, Feuer EJ, Chen MH, Johnson CD.

Radiology. 2011 Nov;261(2):487-98. doi: 10.1148/radiol.11102411. Epub 2011 Aug 3.

2.

Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Savarino JE, van Ballegooijen M, Kuntz KM, Zauber AG.

J Natl Cancer Inst. 2010 Aug 18;102(16):1238-52. doi: 10.1093/jnci/djq242. Epub 2010 Jul 27.

3.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
4.

Impact of computer-aided detection on the cost-effectiveness of CT colonography.

Regge D, Hassan C, Pickhardt PJ, Laghi A, Zullo A, Kim DH, Iafrate F, Morini S.

Radiology. 2009 Feb;250(2):488-97. doi: 10.1148/radiol.2502080685.

PMID:
19188317
5.

Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.

Lucidarme O, Cadi M, Berger G, Taieb J, Poynard T, Grenier P, Beresniak A.

Eur J Radiol. 2012 Jul;81(7):1413-9. doi: 10.1016/j.ejrad.2011.03.027. Epub 2011 Mar 27.

PMID:
21444171
6.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
7.

Value-of-information analysis to guide future research in colorectal cancer screening.

Hassan C, Hunink MG, Laghi A, Pickhardt PJ, Zullo A, Kim DH, Iafrate F, Di Giulio E.

Radiology. 2009 Dec;253(3):745-52. doi: 10.1148/radiol.2533090234. Epub 2009 Sep 29.

PMID:
19789242
8.

Cost-effectiveness analysis of colorectal cancer screening methods in Iran.

Allameh Z, Davari M, Emami MH.

Arch Iran Med. 2011 Mar;14(2):110-4. doi: 011142/AIM.008.

9.

Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.

Regge D, Iussich G, Senore C, Correale L, Hassan C, Bert A, Montemezzi S, Segnan N.

Trials. 2014 Mar 28;15:97. doi: 10.1186/1745-6215-15-97.

10.

Comparative effectiveness of screening strategies for colorectal cancer.

Barzi A, Lenz HJ, Quinn DI, Sadeghi S.

Cancer. 2017 May 1;123(9):1516-1527. doi: 10.1002/cncr.30518. Epub 2017 Jan 24.

PMID:
28117881
11.

Cost effectiveness of CT colonography for UK NHS colorectal cancer screening of asymptomatic adults aged 60-69 years.

Lee D, Muston D, Sweet A, Cunningham C, Slater A, Lock K.

Appl Health Econ Health Policy. 2010;8(3):141-54. doi: 10.2165/11535650-000000000-00000.

PMID:
20369905
12.

Cost effectiveness and projected national impact of colorectal cancer screening in France.

Hassan C, Benamouzig R, Spada C, Ponchon T, Zullo A, Saurin JC, Costamagna G.

Endoscopy. 2011 Sep;43(9):780-93. doi: 10.1055/s-0030-1256409. Epub 2011 May 27.

PMID:
21623557
13.

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ.

J Natl Cancer Inst. 2009 Oct 21;101(20):1412-22. doi: 10.1093/jnci/djp319. Epub 2009 Sep 24.

14.

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak C, Johanson C, Fischer SE, Lansdorp-Vogelaar I, Kuntz KM.

JAMA. 2016 Jun 21;315(23):2595-609. doi: 10.1001/jama.2016.6828.

15.

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.

Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.

PMID:
23542330
16.

Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.

Knudsen AB, Hur C, Gazelle GS, Schrag D, McFarland EG, Kuntz KM.

Ann Intern Med. 2012 Nov 6;157(9):611-20. doi: 10.7326/0003-4819-157-9-201211060-00005.

17.

Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.

Sharaf RN, Ladabaum U.

Am J Gastroenterol. 2013 Jan;108(1):120-32. doi: 10.1038/ajg.2012.380. Epub 2012 Dec 18.

PMID:
23247579
18.

CT colonography to screen for colorectal cancer and aortic aneurysm in the Medicare population: cost-effectiveness analysis.

Pickhardt PJ, Hassan C, Laghi A, Kim DH.

AJR Am J Roentgenol. 2009 May;192(5):1332-40. doi: 10.2214/AJR.09.2646.

PMID:
19380558
19.

Screening for Colorectal Cancer: An Updated Systematic Review [Internet].

Whitlock EP, Lin J, Liles E, Beil T, Fu R, O'Connor E, Thompson RN, Cardenas T.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Oct.

20.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

Supplemental Content

Support Center